삼천당제약
205,000KRWMarket close of 10/20 (Tue)
Down -2.61%-5,500KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)212,500KRWUp +3.66%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 206,000
- High
- 210,500
- Low
- 200,500
- Day range
- Day range low 200,500 high 210,500, open 206,000, close 205,000, previous close 210,500
- Volume
- 8×10K shares
- 15.7B KRW 0.46× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
7%1-year close range 126,500 to 1,184,000 won, 7% up from the low
7% of the way up from the lowest close in 1 year (252 sessions) · -82.7% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range-2.61%-2.61%, 0.6× the usual (20-session average ±4.21%)That day -2.61% · usual ±4.21% · large-move threshold ±8.4%
- Trading valueusual range0.5×15.7B KRW, 0.5× the 20-session average0.46× the 20-session average · check threshold 3×
- Earningsusual range17.7B KRWOperating income over the last four quarters 17.7B KRW
The other 3 are within the usual range
- Recent filings1Last 14 days
- Foreign & institutional+7.8B KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Filing received 2026-10-08: 반기보고서 (2026.06)
- Q3 report due · 11/16 (Mon) · in 26 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.